Citigroup issued a buy rating on Henry Schein, a company listed on the Nasdaq stock exchange.
1 report, 1 independent
Updated Oct 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup issued a buy rating on Henry Schein, a company listed on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Henry Schein
American distributor of health care products and services
Nothing else this week.
Related events
- Citigroup and Benchmark issued buy ratings for Strategy shares, while MarketBeat reported the consensus rating for the stock.
- Citigroup maintained a market outperform rating for Ethos Technologies Inc. on November 6, 2026.
- Citigroup upgraded its target price and gave a buy rating for Fortrea.
- Citigroup reiterated a market perform rating, Bank of America restated an underperform rating, and Raymond James Financial started coverage for Omega Healthcare Investors, Inc.
- MarketBeat aggregates consensus rating data on Aegon, while Citigroup weighed in and Morgan Stanley downgraded the rating.